269 related articles for article (PubMed ID: 31140154)
1. Amyloid PET imaging in cardiac amyloidosis: a pilot study using
Dietemann S; Nkoulou R
Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154
[TBL] [Abstract][Full Text] [Related]
2. Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.
Dorbala S; Vangala D; Semer J; Strader C; Bruyere JR; Di Carli MF; Moore SC; Falk RH
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1652-62. PubMed ID: 24841414
[TBL] [Abstract][Full Text] [Related]
3. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.
Abrahamson EE; Padera RF; Davies J; Farrar G; Villemagne VL; Dorbala S; Ikonomovic MD
Amyloid; 2023 Jun; 30(2):169-187. PubMed ID: 36411500
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.
Law WP; Wang WY; Moore PT; Mollee PN; Ng AC
J Nucl Med; 2016 Nov; 57(11):1733-1739. PubMed ID: 27307344
[TBL] [Abstract][Full Text] [Related]
5.
Papathanasiou M; Kessler L; Carpinteiro A; Hagenacker T; Nensa F; Umutlu L; Forsting M; Brainman A; Kleinschnitz C; Antoch G; Dührsen U; Schlosser TW; Herrmann K; Rassaf T; Luedike P; Rischpler C
J Nucl Cardiol; 2022 Apr; 29(2):779-789. PubMed ID: 33025472
[TBL] [Abstract][Full Text] [Related]
6. Quantification of cardiac amyloid with [
Möckelind S; Axelsson J; Pilebro B; Lindqvist P; Suhr OB; Sundström T
Amyloid; 2020 Sep; 27(3):191-199. PubMed ID: 32400202
[No Abstract] [Full Text] [Related]
7. Advances in PET-Based Cardiac Amyloid Radiotracers.
Gallegos C; Miller EJ
Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600
[TBL] [Abstract][Full Text] [Related]
8. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
Rinne JO; Wong DF; Wolk DA; Leinonen V; Arnold SE; Buckley C; Smith A; McLain R; Sherwin PF; Farrar G; Kailajärvi M; Grachev ID
Acta Neuropathol; 2012 Dec; 124(6):833-45. PubMed ID: 23053137
[TBL] [Abstract][Full Text] [Related]
9. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.
Antoni G; Lubberink M; Estrada S; Axelsson J; Carlson K; Lindsjö L; Kero T; Långström B; Granstam SO; Rosengren S; Vedin O; Wassberg C; Wikström G; Westermark P; Sörensen J
J Nucl Med; 2013 Feb; 54(2):213-20. PubMed ID: 23238792
[TBL] [Abstract][Full Text] [Related]
10. Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?
Lhommel R; Sempoux C; Ivanoiu A; Michaux L; Gerber B
Clin Nucl Med; 2014 Aug; 39(8):747-9. PubMed ID: 24978329
[TBL] [Abstract][Full Text] [Related]
11. 18 F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy : Timing Matters.
Han EJ; Sung YE; Jung MH; O JH; Youn JC
Clin Nucl Med; 2022 Dec; 47(12):1074-1076. PubMed ID: 36240762
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Amyloid Quantification Using
Clerc OF; Cuddy SAM; Robertson M; Vijayakumar S; Neri JC; Chemburkar V; Kijewski MF; Di Carli MF; Bianchi G; Falk RH; Dorbala S
JACC Cardiovasc Imaging; 2023 Nov; 16(11):1419-1432. PubMed ID: 37676210
[TBL] [Abstract][Full Text] [Related]
13. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
14. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
15. A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement.
Manwani R; Page J; Lane T; Burniston M; Skillen A; Lachmann HJ; Gillmore JD; Fontana M; Whelan C; Hawkins PN; Wagner T; Wechalekar AD
Amyloid; 2018 Dec; 25(4):247-252. PubMed ID: 30661419
[No Abstract] [Full Text] [Related]
16. Visualization of multiple organ amyloid involvement in systemic amyloidosis using
Ezawa N; Katoh N; Oguchi K; Yoshinaga T; Yazaki M; Sekijima Y
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):452-461. PubMed ID: 28891012
[TBL] [Abstract][Full Text] [Related]
17. [(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.
Thal DR; Beach TG; Zanette M; Heurling K; Chakrabarty A; Ismail A; Smith AP; Buckley C
Alzheimers Dement; 2015 Aug; 11(8):975-85. PubMed ID: 26141264
[TBL] [Abstract][Full Text] [Related]
18. Extracardiac
Wagner T; Page J; Burniston M; Skillen A; Ross JC; Manwani R; McCool D; Hawkins PN; Wechalekar AD
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1129-1138. PubMed ID: 29651545
[TBL] [Abstract][Full Text] [Related]
19. Quantitative [
Khor YM; Cuddy S; Harms HJ; Kijewski MF; Park MA; Robertson M; Hyun H; Di Carli MF; Bianchi G; Landau H; Yee A; Sanchorawala V; Ruberg FL; Liao R; Berk J; Falk RH; Dorbala S
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1998-2009. PubMed ID: 31807884
[TBL] [Abstract][Full Text] [Related]
20. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
